Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Maida Vale Capital AB | 25,58 | 25,58 | 2024-12-23 |
| Nordnet Pensionsförsäkring | 7,96 | 7,96 | 2024-12-23 |
| Heli Kurjanen | 3,71 | 3,71 | 2023-12-31 |
| Quartier Latin AB | 3,07 | 3,07 | 2024-12-23 |
| Vidarstiftelsen | 2,95 | 2,95 | 2024-12-23 |
| Avanza Pension | 2,36 | 2,36 | 2024-12-23 |
| Mika Kurjanen | 1,93 | 1,93 | 2023-12-31 |
| Henrik Hahn | 1,06 | 1,06 | 2024-12-23 |
| Petter Eriksson | 0,98 | 0,98 | 2024-12-23 |
| Tarek Nabil Shoeb | 0,76 | 0,76 | 2024-12-23 |
2025-05-07 Delårsrapport 2025-Q1
2025-05-20 Årsstämma 2024
2025-08-13 Delårsrapport 2025-Q2
2025-11-06 Delårsrapport 2025-Q3
2026-02-25 Bokslutskommuniké 2025